Work

A case of metastatic dysgerminoma treated with two cycles neoadjuvant chemotherapy followed by fertility-sparing minimally invasive surgery

Year: 2019

Type: article

Abstract: •Neoadjuvant chemotherapy (NACT) followed by fertility-sparing surgery is a feasible treatment of metastatic dysgerminoma•As few as two cycles of NACT may result in enough of a tumor response for fertility-sparing surgery to be possible.•Tumor lysis syndrome is a possibility when administering chemotherapy to patients with metastatic dysgerminoma.

Source: Gynecologic Oncology Reports

DOI: 10.1016/j.gore.2019.04.003

Authors: Katrin E. Eurich, Elizabeth Swisher, Mirna Toukatly, Lisa Koch, Emily S. Wu

Institution: University of Washington

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $650